There is significant need for development of water-soluble general anesthetics because they have several advantages compared to lipid-soluble general anesthetics. The application of water-soluble anesthetics is particularly preferential for elderly (people 65 or older). Since they have increased adipose tissue and decreased body water, the volume of distribution of lipid-soluble anesthetics increases in elderly patients, which retards the elimination of these agents and prolongs their half-life. At the same time, elderly people are more sensitive to the most widely used lipid-soluble general anesthetic, propofol, an effect that correlates with their increased vulnerability to delirium and cognitive decline in the postoperative period. These complications, in turn, are associated with increased mortality.
For the development of novel water-soluble anesthetics, the availability of assays for screening of suitable candidate molecules is instrumental. While assays for chemotypic high-throughput screening are currently being developed, and assays for behavioral screening of novel anesthetic compounds are already available, high-throughput assays that evaluate the neurophysiological effects, particularly at the systems level, are missing.
The assay described herein has great potential to fill the gap between chemotypic screening and behavioral screening by providing an assay whose setup costs are only a fraction of the costs for establishing one of the traditional physiological setups. Equally important, the assay produces high-quality results much faster than any of the traditional assays based on in vivo or in vitro physiological recording.
An in vivo assay for physiological evaluation of water-soluble general anesthetics has been developed. This assay is based on the effects of anesthetics on the frequency of the pacemaker nucleus, an endogenous neural oscillator in the brainstem, of the weakly electric fish Apteronotus leptorhynchus. Alterations of its frequency are determined using the fish's electric organ discharge (EOD) as a readily available proxy. The effects of anesthetics on the EOD frequency can be utilized to screen compounds for possible anesthetic properties, and to evaluate how such active compounds affect neural activity in the central nervous system at a systems level.
This disclosure describes the setup of the assay and outlines the algorithm used for automatic measurement of the EOD frequency, including transient modulations. The assay's applicability is illustrated by showing the effect of three water-soluble anesthetics—urethane, MS-222, and eugenol—on the EOD frequency. Finally, the advantages of the described assay compared to other screening approaches is described.
The problem of physiological screening of water-soluble general anesthetics is addressed. Instead of recording neural activity directly from a specific site in the central nervous system, a behavioral proxy of such activity was us. This is possible because the system on which the assay is based (an endogenous brainstem oscillator called the pacemaker nucleus) drives the behavioral activity (the electric organ discharge of the electric fish) in a one-to-one fashion. As a result, the frequencies of the endogenous neural oscillator and the electric organ discharge are identical. Changes in the frequency of the pacemaker nucleus induced by anesthetics can, thus, be evaluated by monitoring the frequency of the electric organ discharge.
The evaluation of the effect of anesthetic compounds on the neural activity of a structure in the central nervous system by using a behavioral proxy, instead of directly recording the neural activity from this structure, makes the application of the assay relatively simple while producing high-quality results more reliably and in much shorter time than possible by using physiological approaches. Moreover, the costs for the setup of the assay are only about 10% of the costs for establishing a setup for direct in vivo or in vitro physiological recording.
The assay described herein delivers results with high reliability (almost every run yields high-quality experimental data) and high reproducibility (runs using different animals but same anesthetics yield data that are fundamentally very similar, whereas runs using the same animal but different anesthetics yield data that indicate fundamental differences in the effects of different drugs). In vivo and in vitro neurophysiological assays notoriously suffer from failures, resulting in low yield.
There is a need for general anesthetics with improved safety and specificity. In particular, the traditional view that anesthesia depends on lipid solubility of anesthetic agents has been shown to be a misunderstanding of experimental data. Lipophilic anesthetics require formulations in lipid-containing solvents, which bears several serious disadvantages. For example, propofol, one of the most widely employed general anesthetics, is a lipid-based emulsion formulation of the active drug diisopropyl phenol. This emulsion tends to separate when other chemicals are added or when temperature and pH change. The lipid-based emulsion of propofol also contributes to hyperlipidemia, bears the risk of infection by bacterial contamination, and causes pain on injection. Moreover, the soybean oil and egg lecithin solubilizing agents are potential allergens.
The application of water-soluble anesthetics can be useful for elderly (people 65 or older). Since they have increased adipose tissue and decreased body water, the volume of distribution of lipid-soluble anesthetics increases in elderly patients, which retards the elimination of these agents and prolongs their half-life (for review see Rivera and Antognini 2009). At the same time, elderly people are more sensitive to propofol, an effect that correlates with their increased vulnerability to delirium and cognitive decline in the postoperative period. These complications, in turn, are associated with increased mortality.
Anesthetics preferably are water soluble. Efforts for developing such drugs have traditionally focused on modifying the chemical structure, and thereby the activity, of existing drugs. Only in recent years have unbiased high-throughput approaches been established to screen large libraries of compounds for anesthetic ligands. Such chemotypic screens have been complemented by high-throughput behavioral screening, such as the Xenopus tadpole assay, to validate the anesthetic properties of the identified ligand. A high-throughput physiological approach to evaluate anesthetic ligand candidates at a systems level was needed. Existing electrophysiological approaches can be designed for examining the neurophysiological effect of anesthetics in vitro at the levels of ion channels of single cells but not at the systems level. Moreover, the application of these assays can be time-intensive and expensive, and they can require highly skilled scientific personnel for their operation.
The neuro-behavioral assay described here may fill this gap. Since the frequencies of the EOD and the neural activity of the pacemaker nucleus are identical, and the EOD can be readily quantified, this in vivo behavioral assay provides a robust proxy for examining the effect of anesthetic-drug candidates on neural function in the central nervous system at the systems level. The costs for establishing this assay are roughly one order of magnitude lower than the costs for an electrophysiological setup. The throughput rate of the individual assay is higher than that of traditional electrophysiological testing assays. These advantages make the Neuro-Behavioral Assay an alternative to these traditional physiological-testing methods for initial high-throughput neurophysiological screening of compounds, and for complementing existing in vitro-physiological methods as part of an in-depth evaluation strategy.
For the assay, adult brown ghost knifefish (Apteronotus leptorhynchus; Gymnotiformes, Teleostei), with total lengths of approximately 12-15 cm, are used. The fish are imported from their natural habitat in South and Central America.
At least 1 week before using the assay for the first run, the fish is transferred from a community tank to an isolation tank (50 cm×30 cm×30 cm) equipped with aquarium thermostat heaters and air-driven corner filters. The fish is kept in aquarium water prepared by adding a mixture of inorganic salts (81 mmol/L MgSO4·7H2O; 107 mmol/L KCl; 12 mmol/L NaH2PO4·2H2O; 732 mmol/L CaSO4·2H2O) to deionized water until a water conductivity of approximately 150-300 μS/cm is reached. Water temperature, determined during the experiments every 10 min with a calibrated high-precision (accuracy+0.05° C.) digital thermometer, is kept in the range of 25.0-28.0° C. across all assays. Variation is limited to 1.0° C. in an individual assay. A 12:12 h light:dark photoperiod is maintained with a timer. The fish are fed red mosquito larvae daily, after the assay run on that day has been completed.
In each isolation tank, an opaque cylindrical plastic tube (length: 190 mm; inner diameter: 38 mm; outer diameter: 42 mm) provides shelter and is readily accepted by the fish, particularly during the light phase, when individuals of this nocturnal species spend most of the time in shelter places. A pair of stainless-steel electrodes is mounted on the inside of each tube (see section 4.1.2, ‘EOD recording,’ below).
Conduction of the assay requires approval by the Institutional Animal Care and Use Committee.
Differential recording of the fish's EOD is done through the pair of stainless-steel electrodes built into the shelter tube (
The signal is AC amplified (gain: 30×; low-pass filter: none; high-pass filter: 200 Hz) and then digitized at a sampling rate of 50 kHz.
The sampled time-voltage data (ti, vi), i=1, . . . , N, are filtered in subsequent, 1-s-long windows using a bandpass filter with frequency band [0.8, 1.2]×f0, where f0 is the fundamental frequency determined from the power spectrum of the signal within the associated time window.
The filtered time series data (ti, Vi), i=1, . . . , N, are further processed to determine the EOD frequency at a higher time resolution. First, tuple j containing the indices of all instants where the filtered signal changes sign to a positive value is determined:
j=(i|sgn(Vi+1)−sgn(Vi)>0, i=1, . . . ,N)
Then, tuple t+ of time instances when the signal crosses the time axis upwards is calculated using interpolation:
Here M=|j| denotes the number of elements in j (the number of all crossings). Finally, time-frequency pairs (Tk, fk) are computed as
for k=1, . . . , M−m. Here m=10 is the number of averaged time periods used for EOD frequency calculation.
Since the EOD frequency of A. leptorhynchus is temperature dependent, all measured frequencies are adjusted to a reference temperature (arbitrarily chosen to be 26° C.) so that discharge frequencies at different water temperatures can be compared. This adjustment of a frequency f1 (in Hz) measured at a temperature T1 (in ° C.) to the reference temperature T2=26° C. is calculated as
where f2 is the expected frequency at T2 and Q10=1.56, as determined empirically.
To characterize the variability of the EOD frequency, frequency measurements of the recorded EOD are sampled every 1 min over 30 min, and the coefficient of variation (cv), defined as
cv=(standard deviation/mean)×100(%)
is computed.
Previous research has shown that transient modulations of the EOD may occur, both spontaneously and through stimulation with electric signal mimicking the EOD of a conspecific. These modulations are brief (several tens of milliseconds) and involve frequency increases. They are commonly referred to as ‘chirps.’
To identify chirp instances, the time-frequency data {(Tk, fk)}k=qq+n
f
base,q=median({fq+p−1}p=1n
Then the frequency data was shifted and normalized inside each q=1, 2, . . . time window as
Inside each q=1, 2, . . . time window, the time axis was also shifted to the midpoint of the window:
We, then, fit the single-parameter function (with parameter α)
to the data set {(ξp,q, ϕp,q)}p=0n), with
is reported, and collected into a tuple qε the instances of time windows where the coefficient of determination
of the fitted curve and the maximum frequency rise
are both above thresholds εR
q
ε=(q|>εR
Subsequently, using Algorithm 1, contiguous segments of successive windows are identified within qε and for each segment the time window q associated with the maximum value is reported together with the corresponding parameter
and maximum frequency rise Δfq.
, Δfq, q = 1, ... , M − nwind − 1
value and associated parameters
≤ εR
> εR
> εR
≤ εR
,
, Δfw
Nonlinear regression is performed on data points within these time windows using the three-parameter model Ψ(ξ; α, Δf, τ)=Δf Φ(ξ−τ; α) with initial parameters α=, Δf=Δfq, and τ=0. Finally,
as time instance, as maximum frequency rise and {circumflex over (d)}chirp,q=ln(7+4√{square root over (3)})/{circumflex over (α)}q is reported as duration of a chirp for each q reported time window with parameter estimates {circumflex over (α)}q,
, {circumflex over (τ)}q. Here the formula for chirp duration corresponds to the half prominence of Ψ(ξ; {circumflex over (α)}q,
, {circumflex over (τ)}q).
The implemented values of parameters for the above-described method are summarized in Table 1.
To demonstrate the applicability of the assay for physiological evaluation of water-soluble anesthetics, the effects of urethane and MS-222 (also known as tricaine methanesulfonate or 3-aminobenzoic acid ethyl ester methanesulfonate) on the EOD frequency and chirp rate were examined in two experiments.
In Experiment 1, whether urethane or MS-222 anesthesia had an effect on EOD frequency was examined. The experimental design is outlined in
The fish was left in the anesthetic solution until both anal fin undulation and opercular movement ceased. It was then returned to its isolation tank where recording of the EOD continued for 180 min. For urethane anesthesia, treatment including transfer to and from the beaker took between 4-5 min. MS-222 anesthesia required longer exposure to the anesthetic so that the entire treatment lasted between 9-15 min. Control experiments were designed such that the handling of the fish and the time the fish spent outside its isolation tank were similar to the corresponding anesthesia experiments (urethane control: 5-8 min; MS-222 control: 7-10 min).
The effect of urethane and MS-222 was tested in 8 fish each. Every anesthesia experiment was paired with a control experiment, and they were run on 2 different days. The order of the anesthesia experiment and the control experiment was determined using a semi-random design, ensuring that in 4 fish the urethane-anesthesia experiment was followed by the control experiment, whereas in the other 4 individuals the control was carried out before the urethane experiment. Apart from this constraint, the assignment of the 8 experimental pairs to the fish was random.
Out of the 12 fish in Experiment 1, 4 fish were used in both the urethane and MS-222 experiments (and corresponding control experiments), whereas the remaining 8 fish were involved in the testing of only one of the two anesthetics. Any fish that was reused was given ≥1 week between urethane anesthesia and MS-222 anesthesia to ensure that the fish was well-adjusted before further testing. In no case was there any indication that prior exposure to one of the two anesthetics had an impact on the effect of the other anesthetic, as determined based on EOD frequency.
After Experiment 1 established that both urethane and MS-222 affect the EOD, Experiment 2 was used to examine the time course of the changes in EOD frequency during the fish's exposure to the respective anesthetic.
First, the fish's baseline EOD was recorded for 10 min. Then, the entire electrode tube with the fish inside was transferred from the isolation tank into a plastic tank (30 cm×20 cm×20 cm) containing either 2.5% urethane or 0.02% MS-222 in aquarium water. Based on the average time the fish had spent in the anesthetic solution in Experiment 1, the fish's EOD was recorded in the plastic tank for about 6 min if urethane was used as an anesthetic, and about 10 min if MS-222 was employed.
The Related-Samples Sign Test was used to assess differences in temperature-adjusted EOD frequencies between groups. Significance levels were set at p<0.01 (2-tailed).
The median frequencies of the EODs generated by the 12 fish in this study ranged from 626 Hz to 869 Hz (29 measurements taken at equal intervals during the 32 pre-treatment recordings) (
In each of the 8 fish, urethane anesthesia resulted in a fast and pronounced drop in EOD frequency. Immediately after returning the anesthetized fish from the beaker with the urethane solution to their isolation tanks, the EOD frequency was 104-142 Hz (median: 133 Hz) lower than the corresponding median baseline frequency (
Analysis of the temporal dynamics of the EOD frequency during urethane anesthesia revealed two phases (
In each of the 8 fish, MS-222 anesthesia resulted in a fast drop in EOD frequency, which was more pronounced than the decrease observed after urethane anesthesia. Immediately after returning the anesthetized fish from the beaker with the MS-222 solution to their isolation tanks, the EOD frequency was 129-279 Hz (median: 168 Hz) lower than the corresponding median baseline frequency (
The time course of frequency change during MS-222 anesthesia differed markedly from that during urethane anesthesia (
After both urethane and MS-222 anesthesia, the EOD frequency started to return to baseline levels as soon as the fish was transferred from the beaker with the anesthetic solution to its isolation tank (
Here t=0 corresponds to the time instance when the fish was returned to its tank from the beaker with the anesthetic solution. At this time instance, the EOD frequency is given by parameter a. As t increases, F(t) approaches the line l(t):=c+d t, while parameter b controls the shape of the curve between a and l(t). It is important to note that this model is valid only until the frequency recovers to the baseline at time tr. This time instance is slightly different for each fish and varies around 3 hours for urethane and 1 hour for MS-222.
Parameters a, b, c, and d were identified using robust nonlinear regression. The resulting curves are displayed together with ratios based on the measured data points in
In each of the 8 fish, urethane anesthesia resulted in a manifold increase in the number of chirps produced, compared to baseline levels (
During urethane anesthesia, the temporal dynamics of chirping were highly variable among the 3 individual fish examined (
MS-222 anesthesia resulted in a rise in the rate of chirping (
Like the temporal dynamics of chirping during urethane anesthesia, the time course of chirping during MS-222 anesthesia was highly variable among individuals (
Over the last few decades, legal requirements for minimizing pain, suffering, or distress inflicted upon protected animals during experiments have prompted the search for suitable anesthetics and the optimization of methods used for anesthesia. Ideal anesthetics are cheap and readily available; easy to administer and have minimal toxic effects on the animal, the handler, and the environment; provide a wide margin of safety; induce anesthesia rapidly and lead to quick recovery after removal of the animal from the anesthetic. Moreover, if the research project involves examination of nervous function, the effect of the anesthetic on the neural system under study should be minimal.
For anesthesia in fish, no currently available drug meets all the above requirements, but several agents satisfy some of them. For each of the common drugs, doses have been established that induce and/or maintain anesthesia in selected fish taxa. However, a significant gap in knowledge exists about possible neural effects of these anesthetics. To address this issue, a neuro-behavioral assay was recently developed. The unique feature of this in-vivo tool is that a well-defined and readily accessible behavior serves as a proxy of the pattern of the neural command signals that drive the frequency of this behavior.
The behavior utilized by the assay is the electric organ discharge (EOD) of the weakly electric fish Apteronotus leptorhynchus. These discharges are generated continuously at frequencies of approximately 650-1,000 Hz, with males occupying a frequency band between 700 Hz and 1,000 Hz, and females discharging within a frequency band ranging from 650 Hz to 800 Hz, at a water temperature of 26° C. The EOD is generated by an electric organ composed of axonal terminals (so-called electrocytes) of modified spinal motoneurons (so-called electromotoneurons). The synchronized discharges of individual electrocytes constitute the EOD.
The frequency of the EOD is controlled by the frequency of the oscillations of a central pattern generator in the medulla oblongata, the pacemaker nucleus (Pn). Its neural output drives the EOD in a one-to-one fashion, i.c., the frequency of the EOD equals the frequency of the synchronized oscillations of the Pn. Thus, the frequency of the EOD can be used as a proxy of the frequency of the Pn oscillations.
In fish similar in size to the ones used in the present study, the Pn consists of roughly 200,000 cells, of which approximately 5,000 are neurons. However, neuroanatomical and neurophysiological evidence, as well as simulations based on computational modeling, suggest that a relatively small neural network of approximately 90 pacemaker cells and 20 relay cells is sufficient to produce the sustained high-frequency oscillations of the Pn. The pacemaker cells are connected via chemical and electrotonic synapses with each other and the relay cells. The latter project to the spinal electromotoneurons.
Modulations of the EOD involve changes in frequency and/or amplitude. Some of them are limited to a few milliseconds. The most common type of these transient modulations is chirps, which consist of specific frequency increases and amplitude decreases. At the other extreme are modulations that become manifest in the course of weeks, such as frequency decreases experimentally induced by β-estradiol; they mimic the development of the sexual dimorphism in EOD frequency in A. leptorhynchus.
Neurophysiological experiments and simulations based on computational modeling have suggested two major types of neural mechanisms underlying EOD modulations. One type operates within the Pn. For example, changes in potassium equilibrium potential caused by alterations in the capacity of astrocytes to buffer extracellular K+ have been proposed to mediate changes in EOD frequency. A second type is based on input received by the Pn from other brain regions. One of these inputs is potentially involved in mediating the effect of eugenol on the EOD, as will be discussed in detail below. This excitatory input is received by the relay cells from the mesencephalic sublemniscal prepacemaker nucleus (SPPn) via NMDA receptors. The SPPn, in turn, is under tonic inhibition from a subnucleus of the nucleus electrosensorius in the diencephalon, the nE↓. The latter input utilizes GABA as a transmitter and activates GABAA receptors.
A neuro-behavioral assay is employed to examine the effect of eugenol on the EOD of A. leptorhynchus. This phenylpropanoid is the major active component of clove oil; other active ingredients are isoeugenol and methyl-eugenol. Clove oil and each of its three active ingredients have been widely used as fish anesthetics. Yet, only very recently possible effects of eugenol on physiological functions in the central nervous system (CNS) have attracted attention by investigators. The results of our investigation indicate a pronounced, dose-dependent effect of eugenol on the frequency of the neural oscillations of the Pn, commencing within less than a minute after the fish's exposure to the anesthetic and lasting for up to 30 min after the fish's removal from the immersion solution. These findings call for caution when conducting neurophysiological experiments on fish under general anesthesia with eugenol.
A total of 8 adult (approximately 2-year-old) A. leptorhynchus, collected in their natural habitat in Colombia and obtained through a tropical fish importer (Segrest Farms, Gibsonton, Florida, USA), were used in this study. Their total lengths (body weights) ranged from 122 mm to 157 mm (4.0 g to 6.9 g), with medians of 135 mm and 6.1 g, respectively. The baseline EOD frequencies of the fish indicated that this sample contained both males (high frequencies) and females (low frequencies).
The fish were kept isolated in their home tanks (50 cm×30 cm×30 cm) under a 12:12-h light:dark photoperiod at water temperatures of 26-29° C., conductivities of 180-310 μS/cm, and pH values of 7.7-7.9. Each tank was equipped with an opaque cylindrical tube (length: 190 mm; inner diameter: 38 mm; outer diameter: 42 mm), which provided shelter for the fish. During the experiments, the water temperature was sampled every 10 min with a calibrated digital thermometer (Fisher Brand, Model 15-077-8, 11.705,843; Thermo Fisher Scientific, Waltham, Massachusetts, USA; accuracy±0.05° C.).
Differential recording of the fish's EOD was performed through a pair of stainless-steel electrodes built into the shelter tube (
For calculation of EOD frequency, the method described by Eske et al. (2023) was implemented using MATLAB version R2021b with the following modifications: The time series data were filtered in a moving time window using a bandpass filter with frequency band [0.4, 1.4]×fd,k, where fd,k is the dominant frequency of window k inside the frequency range [0.9, 1.1]×fd,k−1 determined by the previous window's dominant frequency fd,k−1. For each window k=1, 2, . . . , the dominant frequency fd,k was computed based on the power spectrum of the time series data using fast Fourier transform and the “findpeaks” function of MATLAB. The initial dominant frequency fd,0 was determined as the dominant frequency of the baseline recording.
All frequencies were adjusted to a reference temperature of 26° C., using a Q10 of 1.56.
The variability of sampled EOD frequency measurements was characterized by computing the coefficient of variation (cv), defined as
The method described in Eske et al. (2023) was employed for the detection of chirps. This method assumes that the frequency shape of chirps normalized by the peak frequency rise is described in time by function
where ξ is the time coordinate measured from the chirp's peak frequency and α is an unknown parameter identified by the chirp detection method (
The EOD frequency of each recording was normalized with respect to its baseline frequency. For each eugenol concentration, the following model was fitted on the resulting normalized frequency data points after the fish's exposure to the anesthetic solution:
Here t=0 corresponds to the time instant when the fish was returned to its home tank. The fitting of model parameters a, b, c, and d was carried out according to the method described in.
Statistical analysis of the data was performed using R version 4.2.3. Throughout this paper, significance levels were set at p<0.01 (2-tailed).
To assess differences in the change of EOD frequency and chirp rate after anesthesia, the Related-Samples Sign Test using the “rstatix” package in R was employed. To minimize the number of fish involved in our experiments, we chose the smallest number of fish n required for significance under the expected test statistic (0 or n): n=[1−log2(0.01)]=8 was chosen.
To assess dose-dependent differences in recovery, Split-Plot ANOVA based on the following linear mixed effects model were used:
Y
ijk=δ0+δ1ci+βj(i)+δ2tk+δ12citk+εijk (4)
Here, Yijk denotes the measured normalized frequency data after anesthesia, with the indices being associated with eugenol treatment i∈{0, . . . ,3} (i=0 corresponds to control), fish j∈{1, . . . ,8}, and time instance k∈{1, . . . ,360}. Parameter δ0 is the overall mean, δ1 denotes the effect of eugenol concentration ci, βj(i)˜(0, σβ2) is the random effect of fish j under treatment i, δ2 is the effect of time tk=k/2 (min), δ12 is the concentration-dependent effect of time, and εijk˜
(0, σε2) is the measurement error (σβ2 and σε2 are unknown variances).
This model assumes that, for a given treatment, the recovery curve of normalized frequency is independent of the fish. To fit this model on the measured data and to assess significance, the “ImerTest” package in R was used.
To determine the time duration of recovery at each eugenol concentration (i>0), time windows q=0, 1, . . . , 345 Eq. 4 on the normalized frequency data Yijk associated with the given eugenol concentration and control were fitted, and with the time window k∈{q+1, . . . , q+15}. For each r=1, 2, . . . , the null hypothesis was tested that in time windows q=1, . . . , r, δ1=0 and δ12=0 both hold. The Bonferroni correction was applied to assess significance and assigned the recovery time tr to the first r value where the null hypothesis was not rejected.
To examine the effect of eugenol on EOD frequency and chirping behavior, the following experiments were conducted using 8 fish (
Most of the time, fish in the shelter tube maintained an upright position, with their longitudinal axis parallel to the walls of the tube. Forward and backward swimming occurred frequently and appeared to be mediated primarily by high-frequency undulations of the anal fin. Sporadically, the fish made 180° turns around its vertical axis.
Upon exposure of the fish to eugenol, body movements, including undulation of the anal fin, slowed down. When these movements ceased, the fish lost equilibrium and lay on one side. Quantitative analysis of the locomotor activity in 8 fish revealed that the time after which body movements ceased was dose dependent: 1-3 min (mean: 1.8 min) at 30 μL/L eugenol, 1-2 min (mean: 1.4 min) at 45 μL/L eugenol, and 1 min in each fish at 60 μL/L eugenol.
Whereas the time after which the movement of the body stopped at a given eugenol concentration was rather robust, the time after which the anal fin ceased undulating was quite variable. At a concentration of 30 μL/L, in 3 out of 8 fish, the anal fin continued undulating throughout the 5-min exposure of the fish to eugenol. In the other 5 fish, undulation stopped after 1-3 min. At a concentration of 45 μL/L, in 1 out of 8 fish the anal fin continued to undulate throughout the 5-min eugenol anesthesia. In the other 7 fish, the anal fin ceased undulating after 1-3 min. At a concentration of 60 μL/L, the anal fin stopped undulating in each of the 8 fish during anesthesia; this effect required eugenol exposure times ranging from 1 to 4 min.
For determining the baseline EOD frequency of each of the 8 fish, the 30-min recordings of their EODs before each treatment (exposure to water from the home tank only or to eugenol at one of the three concentrations) were used. Then, the median frequencies at 30-s intervals within 1-min time windows of each of these 30-min recordings were computed, yielding a total of 59 median frequency values. As expected, based on our selection criterion, the frequencies of individual fish differed substantially (
In each of the 8 fish examined, eugenol anesthesia resulted, within minutes, in a pronounced decrease in EOD frequency (
Comparison of the medians of the EOD frequency during the 30 min before the start of the anesthesia, and during the 15 min after the onset of anesthesia (i.e., including the 5 min of the fish's exposure to the eugenol solution and the first 10 min after their return to the respective home tank) revealed a significant difference, in response to eugenol, whereas the corresponding control experiments had no significant effect (Related Samples Sign Test, n=8 fish; for details see Table 3).
After transfer of the anesthetized fish back to their home tanks, the EOD frequency returned to baseline levels within approximately 30 min (
Chirp rates were very low prior to anesthesia at any of three eugenol concentrations or to the control treatment (range: 0-1.57 chirps/min; median: 0.05 chirps/min; n=32 pre-treatment EOD recordings over 30 min each, based on 4 pre-treatment recordings in each of the 8 fish) (
In each of the 8 fish, eugenol induced an increase in the number of chirps produced. This effect was largely restricted to the 30 min immediately following the 5-min exposure of the fish to the anesthetic. During this period, at each of the three eugenol concentrations tested, the increase in the number of chirps compared to the 30 min before anesthesia was significantly higher than for the control treatment (p=0.008, Related-Samples Sign Test, n=8 fish) (
In 4 out of 8 fish exposed to 60 μL/L eugenol, the EOD amplitude collapsed to markedly lower levels approximately 3.5 min after the onset of anesthesia (
Clove oil and its active ingredients have been tested as sedatives and anesthetics in numerous fish species. Although their use in fish intended for human consumption is not approved in some countries (such as the United States; FDA 2007), or is conditional upon compliance with maximum residue limits in foodstuffs in other countries (such as the member states of the European Union; European Commission 2011), these compounds have become increasingly common over the last few decades for anesthesia of ornamental fish and fish used in research.
In the present study, it was found that, in A. leptorhynchus, concentrations of 45 μL/L and 60 μl/L eugenol induce anesthesia characterized by total loss of equilibrium and cessation of any movement, including undulation of the anal fin, within 1-4 min. This result is comparable to observations made in two other small-sized tropical/subtropical freshwater fish, zebrafish (Danio rerio) and red garra (Garra rufa). Both species belong to the same teleostean superorder (Ostariophysi) as A. leptorhynchus. In D. rerio, a stage of anesthesia similar to the one induced in A. leptorhynchus was achieved with a concentration of 60 μL/L eugenol within 1.5 min. In G. rufa, total loss of equilibrium and movement, as well as absence of reaction to external stimuli, was observed at eugenol concentrations of 25 μL/L and 50 μL/L after approximately 3 and 1.5 min, respectively.
In the latter investigation, it was furthermore shown that induction time significantly decreases with stepwise increases in eugenol concentrations from 12.5 μL/L to 150 μL/L. This effect is reminiscent of our finding in A. leptorhynchus of a dose-dependent decrease in time at which locomotor activity ceases.
At the eugenol concentrations used in the present study (30-60 μL/L), the fish started to lower the EOD frequency 1-2 min after their transfer into the anesthetic solution. This very short latency is comparable to the latencies observed in a previous investigation when the fish were anesthetized with MS-222 or urethane. However, the latter two anesthetics required significantly higher concentrations for inducing frequency decreases after similar latencies—200 mg/L in the case of MS-222 and 25 g/L in the case of urethane. Since a critical step toward exerting the frequency-lowering effects in the Pn is the ability of anesthetics to cross the blood-brain barrier, it appears reasonable to assume that the efficacy of eugenol in this step is higher than those of MS-222 and urethane. As is well established in clinical practice, almost all drugs that interfere with brain function are lipid soluble and small, with a molecular mass<400 Da. Each of the three anesthetics used in our two studies meet the latter criterion (molecular masses: eugenol, 164 g/mol; MS-222, 261 g/mol; urethane, 89 g/mol). Unfortunately, the octanol-water partition coefficients are available only for eugenol (log kow=2.49) (National Center for Biotechnology Information 2023a) and urethane (log kow=−0.15). However, these data support our hypothesis that, while the solubility of eugenol in water is sufficient for dissolving the compound at the concentrations used in the present study), its lipophilicity enables the molecule to cross the blood-brain barrier through lipid-mediated transport rapidly and with high efficacy.
Despite the wide use of eugenol and related compounds as anesthetics in fish, little is known about their effects on CNS function. A first attempt to fill this critical gap in knowledge was undertaken recently by employing an antidromic-stimulation regime of the axon of the Mauthner cell to study the effect of different concentrations of isoeugenol on the generation and propagation of action potentials in goldfish (Carassius auratus). No effect was observed at 10 mg/L and 20 mg/L, even after exposure of the fish to the anesthetic for more than 1 hour. At 40 mg/L isocugenol, a slight decrease in the slope of action potentials was evident after 10-30 min. Only at the highest concentration tested, 60 mg/L, and exposure of the fish for at least 10-30 min, additional aspects of the action potential were affected, including peak amplitude and duration. However, even the latter changes were rather modest, compared to controls. By contrast, sensory stimulation by brief acoustic or visual pulses had more pronounced effects on postsynaptic potentials induced in the Mauthner neuron, with visual stimuli evoking stronger responses than acoustic stimuli. The authors interpreted these results as evidence that isocugenol acts primarily locally on sensory systems, instead of affecting action potential generation and propagation, as well as chemical and electric transmission, at the level of central neurons. Nonetheless, the limitation of their study to just one neuron, and the lack of experiments examining possible effects of isoeugenol on synaptic transmission, hamper such generalization.
In contrast to this study, the findings of the present investigation demonstrate that eugenol can induce strong dose-dependent effects on the function of a brain system, even at low concentration and within a few minutes. These observations are consistent with the results of experiments carried out on rat neocortical and hippocampal slices that demonstrated reversible and dose-dependent suppression by eugenol of epileptiform field potentials and spreading depression, presumably via inhibition of synaptic plasticity. On the other hand, it is important to keep in mind that direct comparison of our study and that of Machnik et al. (2023) is not possible because not only were different fish species (A. leptorhynchus vs. C. auratus) and different neural systems (pacemaker nucleus vs. Mauthner neuron) examined but also different, though closely related, agents (eugenol vs. isocugenol) were employed.
Assaying the EOD frequency as a proxy of the output frequency of the Pn enabled us not only to analyze, with high temporal resolution, the drop in frequency induced by cugenol, but also to track the recovery of the EOD frequency after the fish's return from the anesthetic solution to the water of its home tank. Although the fish regained equilibrium and locomotor activity, including undulation of the anal fin, within a few minutes (data not shown), the EOD frequency remained reduced significantly longer, for up to 30 min. Both the drop in EOD frequency during anesthesia and the persistence of this effect beyond the immediate state of anesthesia underscore the need to consider the possibility of effects on CNS function whenever neurophysiological experiments on fish are performed under anesthesia with eugenol (or related compounds).
Compared to fish anesthetics tested previously by employing the neuro-behavioral assay, it is notable that the recovery time after eugenol anesthesia is markedly shorter than the recovery time of urethane (approximately 3 hours) and MS-222 (approximately 1 hour). Thus, the relatively short ‘neural’ recovery period of eugenol is another attractive feature of this anesthetic, in addition to the advantages mentioned in section ‘Eugenol as a fish anesthetic,’ above.
In the following, what is known about the pharmacological actions of eugenol to the neural circuitry involved in generating and modulating the output frequency of the pacemaker nucleus, thereby providing a mechanistic model of the effect of this anesthetic on the EOD frequency was compared. A similar model for explaining the effect of eugenol on chirping behavior was not presented. The generation of chirps by the pacemaker nucleus is primarily controlled by a projection to its relay cells, originating in a subnucleus of the central posterior/prepacemaker nucleus, the so-called CP/PPn-C. This control is exerted by glutamatergic synaptic transmission and activation of non-NMDA-type receptors. The CP/PPn-C, in turn, receives a multitude of inputs from other brain regions. However, unlike the connection between the CP/PPn-C and the relay cells, the nature (excitatory, inhibitory) of these inputs to the CP/PPn-C, and the transmitters/receptors involved at their synapses, are unknown. We, therefore, can only speculate that one or more of these inputs are targets of eugenol, and it is this action that results in the increase in chirping.
Several cellular and molecular effects of eugenol have been implicated in the anesthetic activity of eugenol. Notably, its ability to block the generation of nerve impulses and to reduce the excitability of neurons has been postulated to underlie its property as a local and general anesthetic. Possible molecular targets of this action are voltage-gated sodium channels, which are inhibited by eugenol. In Nav 1.7-transfected CHO cells, this molecule preferentially binds to such channels in the inactivated state, thereby driving fast-inactivated channels into slow-inactivated channels. In addition, methyl-eugenol has been shown to exert inhibitory effects on Kv1.5 and, possibly, other potassium channels. The resulting inhibition of K+ currents may lead to clongation of the duration of action potentials and the refractory period.
In the Pn of A. leptorhynchus, the inhibitory effects of cugenol on voltage-gated sodium channels and voltage-gated potassium channels may limit the generation of action potentials and result in the prolongation of action-potentials, respectively. It was proposed that the combination of these effects reduces the frequency of the sustained high-frequency oscillations of the Pn. This hypothesis is congruent with experimental evidence and predictions obtained through modeling, which have suggested the extracellular potassium concentration and the potassium channel conductances as critical determinants of the frequency of the spontaneous oscillations of this brainstem nucleus. The notion that the effect of anesthetics, including MS-222 and urethane as well as eugenol, is mediated by the action of these anesthetics directly in the Pn, but not by modulation of afferent input, receives strong support by electrophysiological recording from isolated Pn tissue.
A second mechanisms that may contribute to the effect of eugenol to induce a drop in EOD frequency is its ability to potentiate GABAA-receptor response. Such an effect has been observed in test systems based on GABAA receptors expressed in Xenopus oocytes and is consistent with the results obtained in a [3H] muscimol-binding assay using rat cortical homogenate. A different effect of eugenol was observed in a study that examined how cugenol affects GABA-induced current in rat trigeminal ganglia and in human embryonic kidney 293 cells expressing the GABAA receptor subtype α1β2γ2. The authors found that it inhibits GABAA current in a reversible, dose-dependent manner. The reason for the discrepancy between the studies of Aoshima and Hamamoto (1999), Sahin et al. (2017), and Kheawfu et al. 2022) on the one hand, and of Lee et al. (2015) on the other, is unclear. Since GABA application to the SPPn lowers the frequency of the EOD, and thus the output frequency of the Pn, a potentiation of the response of GABA receptors received by input from the nE↓ would be expected to result in a decrease of the oscillation frequency of the Pn.
A similar hypothesis related to the potentiation of the inhibitory function of GABAA receptors has been suggested as a mechanistic explanation for the drop in EOD frequency caused by urethane but not MS-222. Remarkably, the time courses of the frequency change during the fish's exposure to eugenol, as shown in the present study, and urethane resemble each other strikingly but both differ significantly from such a plot obtained after MS-222 anesthesia. It is hypothesized that such differences in the ‘signatures’ of the time-frequency plots established through the neuro-behavioral assay reflect differences in the cellular and molecular mechanisms mediating the reduction in EOD frequency.
Signals as vehicles for transmission of information from a sender to a receiver play a pivotal role in animal communication. Broadcasting of signals is mediated by a variety of sensory channels, such as visual, acoustic, tactile, chemical, and electric. Diversity of signals, cither within one sensory modality or by activation of several sensory channels, enables animals to use different signals for different behavioral functions. Within one sensory modality, signal diversity is often achieved by modulation of a generic type of signal. For example, different acoustic signals can be produced by temporal frequency and amplitude modulations, and even rather subtle differences can have profoundly different functional effects.
While acoustic signals are displayed intermittently only (although sometimes for prolonged periods at high rates), some electric fishes produce a generic form of electric signal continuously throughout life. This group includes the brown ghost knifefish (Apteronotus leptorhynchus), a species of the taxonomic order Gymnotiformes that has been intensively studied as model organisms in ethology and neurocthology.
A. leptorhynchus generates such continuous electric discharges with its electric organ composed of modified axonal terminals of spinal motoneurons. The synchronous depolarization of these so-called electrocytes produces electric pulses separated by short inter-pulse intervals. This results in the appearance of a continuous, wave-like signal, commonly referred to as electric organ discharge (EOD). The frequency at which the fish generates the EOD train is determined, in a one-to-one fashion, by the frequency of the neural oscillations of a central pattern generator in the medulla oblongata, the pacemaker nucleus. Within the species-specific frequency range of 650 to 1000 Hz, males discharge at higher frequencies than females, with little overlap between the sexes. Owing to this sexual dimorphism, the EOD contains information about the sex of its sender.
Whereas the species as whole occupies a broad EOD frequency range, the frequency of the discharges of a given individual within this frequency band is highly constant, as indicated by the coefficient of variation (cv=(standard deviation/mean)×100 (%)), which assumes values of less than 0.2% over 30-min. Nevertheless, transient modulations may occur, resulting in diversification of the generic EOD signal. The best-characterized type comprises chirps. In isolated individuals of A. leptorhynchus, chirps are very rarely produced, on average less than once per 10 min. However, during stimulation with the EODs of conspecific fish or with electric signals mimicking such EODs, or after administration of certain drugs, chirp production may increase one-thousand-fold to rates as high as 2 s-1.
Chirps last between some tens and a few hundred milliseconds and involve complex frequency and amplitude modulations. Six distinct chirp types have been identified. They are defined by differences in duration as well as the extent of the frequency and amplitude modulations. Spontaneously produced chirps are predominantly of type 1, whereas most chirps evoked by the EODs of a neighboring fish (or mimics of such electric signals) or by proper pharmacological stimulation belong to
While chirps can be elicited from either sex, at similar rates, through application of pharmacological agents, during electric interaction with conspecifics or in response to electric stimuli mimicking a fish's EOD males chirp at much higher rates than females. In addition, chirps are optimally evoked by electric stimuli with frequencies within±10 Hz of the fish's EOD frequency. Thus, type-2 chirps are typically exchanged by males. Moreover, the chirps produced by two electrically interacting fish are not independent of each other. Instead, the chirps generated by one fish follow the chirps of the other individual with a preferred latency of roughly 500-1000 ms. This ‘echo response’ may serve a communicatory function during social interactions, such as aggressive encounters.
Traditionally, different chirp types have been identified and quantified by visual inspection of time-voltage and time-frequency plots. In addition, threshold-based algorithms and a method based on assumed chirp waveform have been used for chirp detection. Whereas these approaches can be successfully employed for the identification of pre-defined chirp types, the definition of chirp categories is subject to the investigator's bias. Moreover, such approaches do not allow detection of possible additional chirp types that remained unnoticed previously.
To address these deficiencies, we have, in the present study, a supervised learning algorithm is developed. Supervised learning is a machine learning paradigm used across many disciplines. Its goal is to learn, from a “ground truth” (GT) data set, a function that assigns proper outputs (in the present study: time instances of chirps and associated chirp types) to inputs (in the present study: time-series frequency and amplitude data). While the suitability of this machine learning paradigm for the unbiased analysis of chirps produced by A. leptorhynchus is demonstrated, it is proposed that similar approaches can be successfully applied to signal analysis in a variety of other ethological and neurocthological systems.
For the present investigation, time-voltage recordings of the EOD containing chirps generated spontaneously or evoked pharmacologically were analyzed. These data had been collected as part of a previous study examining the effect of urethane anesthesia on EOD frequency and chirping behavior in A. leptorhynchus. Eight fish (total lengths: median, 116 mm; range, 107-143 mm; body weights: median, 2.9 g; range, 2.5-4.8 g) were used. Their EOD baseline frequencies varied between 683 Hz and 868 Hz (normalized to frequency values expected at 26° C., using a Q10 of 1.56). The morphological data and EOD frequencies indicate that the fish were approximately 1 year old and included both males and females. Details of the experiments and the recording technique are given in Eske et al (2023). Briefly, each fish was kept in an isolation tank in which a cylindrical plastic tube provided shelter. Differential recording of the fish's EOD was done through a pair of stainless-steel electrodes mounted on the inside of the tube. During recording, the two open ends of the tube were closed with a coarse plastic mesh netting to ensure that the fish did not leave the tube. The EOD of each fish was recorded for 30 min before, and 180 min immediately after, general anesthesia. State of anesthesia was induced by transferring the fish into a glass beaker containing 2.5% urethane dissolved in water from the fish's isolation tank. During the pre-anesthesia session, spontaneous chirps occurred but at very low rates of approximately 1 chirp/30 min. Anesthesia induced a tremendous increase in chirping behavior, resulting, on average, in 1500 chirps during the 30 min immediately following anesthesia. For the present analysis, the 30-min-pre-anesthesia recordings, and the 180-min-post-anesthesia recordings, of the 8 fish were combined, yielding a total of 1,680 min of EOD recording. Employing the supervised learning algorithm, a total of 30,734 chirps were detected in these combined recordings.
The sampled voltage data (ti, vi), i=1, . . . , Mv, were exported from Spike 2 and processed in MATLAB version R2021b. These data were filtered in 3-s windows with 2-s overlap using a bandpass filter with frequency band [0.5, 1.5]×f0, where the fundamental frequency f0 in each 3-s window was determined based on the power spectrum of the signal using fast Fourier transform and the “findpeaks” function of MATLAB.
Using linear interpolation, all time instances were computed where the filtered time-series signal (ti, Vi), i=1, . . . , Mv, crosses the time axis towards positive voltage values:
Here the tuple of all upward crossings t+ contains M=|j| number of elements, with
j=(i: sgn(Vi+1)−sgn(Vi)>0,i=1, . . . ,Mv) (6)
being a tuple containing all indices of the filtered time-series data where the voltage changed sign to a positive value. Finally, for each oscillation interval [t+(k), t+(k+1)], k=1, . . . ,M−1, time instance Tk, and associated frequency fx and amplitude Ak values were computed as
An example of computed time-series data of frequency and amplitude is shown in
Chirp detection by supervised learning
Tuples of equal-time-length time-series data segments
S
n
(r−1)+j=({Tk(r),fk(r),Ak(r)}:Tk(r)∈[Tstart+(j−1)ΔT,Tstart+jΔT]k=1, . . . ,M−1),j=1, . . . n, (10)
were collected from each recording r=1, . . . , nr, where nr is the total number of EOD recordings, and superscript □(r) indicates association with recording r. The time length of segments was determined as ΔT=(Tend−Tstart)/ns. The values of parameters Tstart, Tend, ns, nr, used for the generation of time-series data segments are provided in Table 8.
Using the MATLAB tool shown in
G={({Ti,j,fi,j,Ai,j})}
n, (11)
where {Ti,j, fi,j, Ai,j} is the j-th data point of the i-th GT chirp sample, li denotes the number of data points in the i-th sample, and n is the total number of samples.
The person who collected chirp samples was instructed to include, in each sample, data points prior to and after chirping, associated with the non-modulated, instantaneous “base” frequency of the fish. Hence, it was assumed that each sample includes both pre and post-chirp data points and estimated
the “base” frequency and amplitude of each sample i as
f
base,t=median([fi,j], [f
−j+1]
),
A
base,t=median([Ai,j]z,999 , [A
−j+1]
). (12-13)
where nmed<min (li/2) is an arbitrarily chosen positive integer which we set to nmed=10. Each sample i=1, . . . , n was normalized with respect to the maximum frequency rise according to
and with respect to the base amplitude as
Then, the time values of each sample were centered according to
where rectifier
with
i=4max(sd({φi,k}k=1n
was applied for the elimination of noise and to highlight “meaningful” parts of the frequency sample. Here sd(·) denotes the standard deviation,
Note that here Δ{tilde over ( )}Ti is the difference between the 90% and 10% percentile estimates of the empirical cumulative distribution Hi,·. The above described data processing method is illustrated in
Because our supervised learning method requires uniform size among GT samples, we grouped and resampled all GT samples according to the number of data points that formed the individual GT samples.
After trimming, the size of each GT sample was roughly commensurate with the length of the associated chirp. To distinguish between chirps whose duration have different time scales, GT samples were divided into 3 groups and resampled the members of each r group such that associated samples contained 10r+1 number of points:
G
r={{(Ti,+j,fi,
+j,Ai,
+j)}j=−10
/210
/1 : |{{tilde over (T)}i,j:{tilde over (T)}i,j∈[−3Δ{tilde over (T)}i,3Δ{tilde over (T)}i],1≤j≤li}|∈(10r−1+1,10r+1], 1≤i≤n],r=1,2,3. (23)
Here the fact that all data points inside any GT sample can be located within the associated recording's time-frequency-amplitude data was utilized. For example, if Ti,1 and Tq are from the same recording and that Ti,1=Tq, then any other point j associated with sample i: (Ti,j, fi,j,Ai,j)=(Tq+j−1, fq+j−1,Aq+j−1) can be found.
Note that chirps typically have a duration shorter than 0.5 s, and the highest EOD frequency in A. leptorhynchus is approximately 1000 Hz, therefore GT sample groups Gr, r=1, 2, 3, are able to capture the full length of all chirps.
After resampling, the normalized frequencies and amplitudes (φi,jcen,i+j, ai,jcen,i+j), j=−10r/2, . . . , 10r/2, of each chirp sample i in each GT group Gr were recomputed according to Eqs. 12-15. For ease of notation, in the following, we drop the shift jcen,i in the second subscript index.
For each r, the normalized frequency and amplitude values were collected from Gr
f
r
(i)=[φi−10r/2, . . . , φi,10r/2,]T,
a
r
(i)=[αi,−10r/2, . . . ,αi,10r/2]T, (24-25)
of each sample i associated with the training set into a matrix Xr∈Rmr×2(10r+1) such that
where mr is the total number of samples in Gr associated with the training set. For the further ease of notation, in the following, index r was dropped, as well. The principal components (PCs) of X were determined by performing spectral decomposition as
XTX=PDPT, (27)
where P=[p1, . . . , p2(10r+1)] is an orthogonal matrix and D=diag(λ1, . . . , λ2(10r+1)) is a diagonal matrix, with λ1≥λ2≥. . . ≥λ2(10r+1). Note that here pk is the k-th PC with associated empirical variance λk. The training data set was then projected onto the space of the first N PCS, i.e.,
Y=XPN, (28)
was computed where PN=[p1, . . . , pN].
The projected data YT=[y(1), . . . , y(m)] was modeled using the Gaussian mixture model (GMM)
y
(i)˜(μc,Σc),c˜MC(p1, . . . ,pC), (29)
where N(μc,Σc) is the multivariate normal distribution of the c-th mixture component with mean μc∈RN×1 and covariance Σc∈RN×N, while MC(p1, . . . , pC) is a multinomial distribution with C number of categories and mixing proportions p1, . . . , pC. The unknown parameters were estimated Θ={p1, . . . , pC,μ1, . . . ,μC,Σ1, . . . ,ΣC} of this GMM based on data Y using the “fitgmdist” function of MATLAB. Elimination of outliers After fitting the GMM, each data sample i were assigned to the cluster with maximum posterior probability, i.e., the cluster of sample i was computed according to
for each i=1, . . . ,m, where P(c|i) is the probability that sample i belongs to cluster c, given the observation y(i). Then, the coefficient of determination (CoD) of the frequency component of each sample was computed with respect to its assigned cluster mean as
Here ∥·∥ denotes the L2 norm and
with 1 being a vector of 1−s.
Each cluster c was eliminated for which the 5% percentile of associated CoD values {Ri2: ci=c, 1≤i≤m} was below threshold δR2=0.3. Additionally, each cluster c whose size |{i: ci=c,1≤i≤m}| was below threshold δc=30 was eliminated.
Training yields PCs PN and GMM
y
(i)˜({circumflex over (μ)}c,{tilde over (Σ)}c),c˜MC
({tilde over (p)}1, . . . ,{tilde over (p)}C
), (34)
where C*≤C is the number of kept clusters, with {tilde over ( )}pc={circumflex over ( )}pc/{Σq=1C*pq, and {circumflex over ( )}pc, {circumflex over ( )}μc, {circumflex over ( )}Σc, being the estimated parameters of kept clusters c=1, . . . , C*. To detect chirps in recordings, data points {(Ti+j, fi+j,Ai+j)}j=010r i=1, . . . ,M−10r−1, were analyzed in a moving time window containing 10r+samples (see
f
(i)=[φi,1, . . . ,φi,10r+1,]T,
a
(i)=[αi,1, . . . , αi,10r+1]T, (35-36)
according to formulas Eqs. 12-15 with (Ti,j, fi,j,Ai,j)=(Ti+j−1, fi+j−1,Ai+j−1) and li=10r+1.
At each instance i, our Mahalanobis-distance-based (MDB) detection method first projects the normalized frequency and amplitude data onto the PCs according to
then it determines the kept cluster which is most likely to generate y(i):
Afterwards, our method computes the Mahalanobis distance
d
i=√{square root over ((y(i)−{circumflex over (μ)}c
For any point generated by kept cluster ci, realizations di2 follow a chi-squared distribution with N degrees of freedom: Di2˜N2.
The MDB method collects all i instances, where the squared Mahalanobis distance is below threshold εd2 and the maximum frequency rise is above threshold εf, into the tuple
Each contiguous segment in CMDB corresponds to an identified chirp. In each contiguous segment, the identified chirp was associated with the instance i that has lowest distance di. Threshold εd2 is determined based on a chosen level of significance α such that P(Di2<εd2)=1−α. The MDB method is illustrated in
At each instance i, our coefficient-of-determination-based (CDB) detection method computes the CoD of the frequency component with respect to each kept cluster mean according to
using formulae Eqs. 32-33, and assigns instance i to the cluster with highest CoD value:
Afterwards, the CDB method collects all instances into the tuple cCDB where the CoD value and the maximum frequency rise are both above thresholds εR2 and εf, respectively:
Similarly to the MDB method, identified chirps are associated with contiguous segments in cCDB. In each contiguous segment, the identified chirp is assigned to the instance i that has the highest Ri,ci2 value. The CDB method is illustrated in
In order to assess the performance of the two algorithms detailed above, the time-frequency-shape-based (TFSB) chirp detection algorithm was chosen as a reference described in (Eske et al, 2023). This algorithm is based on the chirp waveform function
which is assumed to characterize, during chirps, the normalized frequency φ with respect to time {tilde over ( )}T. This function is parameterized by a single parameter {tilde over ( )}α that controls chirp duration (see
The TFSB algorithm has 7 hyper-parameters, out of which 5 were fixed (see Table 9), and the remaining 2 were determined via cross-validation.
To determine the optimal hyper-parameter values hopt of detection algorithms, k-fold cross validation was used. In particular, indices i∈iGT associated were randomized with time-series data segments Si and split them onto k number of equal-size folds: iGT,q⊂iGT, q=1, . . . , k. For each iteration step q=1, . . . , k, of cross validation, a single fold iGT,q was used as a test set for determining the performance of the algorithm, while the rest of the folds were used as a training set. Note that only the two supervised algorithms were trained (for details, see Section 2.3.2), while the TFSB algorithm did not involve any training. The performance of each algorithm was determined by computing the false positive and false negative rates for each iteration step q=1, . . . , k, as
where 1(·) is the indicator function, Tj(s) denotes the j-th time instance of chirps detected by the algorithm in time-series data segment Ss, while Ti,1(s) and Ti,l1(s) correspond to the first and last data point of the i-th chirp sample in Gr collected from data segment Ss. Parameters mA,s and mGT,s denote the total number of chirps detected by the algorithm in Ss, and collected manually from Ss, respectively. The overall performance of the algorithm was determined by averaging over all folds:
Note that false positive and false negative rates depend on hyper-parameters h. The hyper-parameters were tuned, such that for a given maximum tolerated average false positive rate rFP, the average false negative rate is minimized, i.e.,
where Ω is the search domain of hyper-parameters. At the maximum tolerated average false positive rate rFP, the lowest achievable average false negative rate is
r
FN(rFP)=
The implemented search domains of hyper-parameters are summarized in Table 10.
For the GT group G2, the lowest achievable average false negative rate rFN of each algorithm were computed at given average false positive rate tolerances rFP (see
To illustrate waveform components that dominate GT group G2, its PCs were computed (
After cross-validation, a model was trined described above based on the entire GT data set G2. An optimal hyper-parameters hopt(rFP=5%) determined via 4-fold cross-validation was used. The cluster means of the model, computed according to Eq. 32, are shown in
The results presented in this paper demonstrate the superiority of our supervised-learning algorithm over traditional methods for analysis of chirps produced by A. leptorhynchus.
The first advantage of our method lies in its versatility, compared to traditional approaches. As shown in Section 3.2, the TFSB method performs well for the herein analyzed signal segments because a single time-frequency waveform (associated with type-2 chirps) dominates the collected GT chirp data set, and this waveform matches well the assumed time-frequency shape. If multiple dominant waveforms are present in the GT chirp data set, or if the assumed time-frequency shape does not match the dominant chirp waveform, the performance of the TFSB method would be significantly worse. Furthermore, the design of a shape function representative of the dominant chirp waveform is rather cumbersome and impacted by the researcher's bias. In contrast, the supervised-learning algorithm autonomously trains chirp waveform models by fitting them to the collected GT chirp data. Given that the GT data set is representative of chirps in the analyzed signal, this algorithm provides an unbiased way for the automatic identification of dominant chirp waveforms in the signal.
The second advantage of our supervised-learning method is its ability to identify, in an unbiased way, possible sub-types of a signal. In the case of chirping behavior in A. leptorhynchus, visual inspection of time-frequency plots and time-voltage plots has suggested six subtypes of this signal. Although, in the present study, the analyzed recordings contained predominantly a single chirp subtype (type-2), our method suggested that further differentiation of this subtype is possible (see Section 3.3).
The third advantage of our method is that, compared to traditional approaches, it extracts more information from the samples used for the validation of the algorithm. Note that only a few traditional approaches validate their algorithm by signals with known chirp types and locations. However, these approaches use the collected set of chirps only to test efficiency, and thus the algorithm itself is not informed by the known chirp content. By contrast, our supervised-learning method takes full advantage of known chirps and utilizes them for both training the algorithm and testing its efficiency.
Although our algorithm trains itself and identifies chirp clusters automatically, it still relies on the collection of GT samples. Consequently, results are still impacted by the bias of the individual who collects the chirp samples of the GT set. This bias can be reduced if multiple individuals carry out chirp collection using the same signal, and if the GT set is assembled based on the overlap across sets collected by different individuals.
When chirps appear in the signal at a low frequency, the time needed for an individual to collect a sufficiently large GT set increases. While the validation of any algorithm requires the collection of all chirps from a test signal, the number of samples needed by our supervised-learning method is higher than the number of samples needed for validation only. Nevertheless, our method can still be advantageous compared to traditional approaches when already detected chirp types are expected in future experiments. In such cases, the cluster shapes from already collected GT sets can be reused. Furthermore, one can even build libraries of cluster shapes which can then be employed to “scan” signals for all formerly identified chirp shapes.
Our method is based on the time-frequency-amplitude signal (Tk, fk,Ak), k=1, 2, . . . . However, the method for the computation of this signal, described in Section 2.2, works only in the case of time-voltage data being generated by a single EOD source. For the analysis of multiple (either synthetic or recorded from fish) simultaneously recorded EOD signals, one must employ a different method) to extract individual times-frequency-amplitude signals.
The presented supervised learning algorithm provides a valuable tool for further examining the function of chirps. In the present study, it has not only enabled us to validate the previous classification of chirps into different subtypes, but also suggested that further differentiation of these subtypes is possible. Whether these sub-subtypes of chirps subserve any behavioral function remains to be examined.
It is likely that other algorithms based on supervised machine learning will exhibit advantages similar to our approach. Thus, the present study might serve as proof-of-principle of the suitability of the supervised-machine-learning paradigm for a broad range of signals analyzed in neuroethology. It is likely that, in future investigations, algorithms based on machine-learning paradigms like the one implemented in the present study will increasingly become standard tools for signal analysis in neurocthological research.
Neuro-Behavioral Assay extended to the monitoring of locomotor activity. The electric organ discharge (EOD) that is recorded as the assayed behavior contains not only information about the frequency and possible modulations of the EOD (‘chirps’) but also about the locomotor activity of the fish. The reason is that whenever the fish changes its relative position to the (fixed) recording electrodes, the recorded amplitude of the EOD is modulated, due to the vector-field property of the electric field produced by the fish (
The unique feature that makes the Neuro-Behavioral Assay so powerful in comparison to other assays for testing of anesthetic compounds is that it assays a behavior that can be readily sampled (the EOD) as a proxy of the neural activity of the brainstem oscillator (pacemaker nucleus) that drives this behavior. This is possible because each volley of command spikes from the pacemaker nucleus results in one discharge of the electric organ, i.e., the frequency of the oscillation of the pacemaker nucleus equals the frequency of the EOD.
By performing extracellular recordings from the isolated pacemaker nucleus, and by exposing this in vitro preparation to various concentration of an anesthetic (MS-222), I have demonstrated that the effect of anesthetics on the EOD frequency (i.e., a dramatic drop in EOD frequency) is due to a direct effect of these anesthetics on the frequency of the synchronized oscillations of the neurons of the pacemaker nucleus (see
Included in the characterization of the Neuro-Behavioral Assay is a negative control to show that the assay does not produce positive results in response to any neuroactive compound but that these results are specific to anesthetics and compounds with sedative effects. For this control, Amantadine was tested, which is used to treat symptoms of Parkinson's disease. This drug was testedat concentrations from 1 μM, to 5 μM, 10 μM, 20 μM, 30 μM, 40 μM, 50 μM, 60 μM, with exposure times of up to 48 hours. Despite the comprehensive testing, no effects of the drug in the Neuro-Behavioral Assay on (a) EOD frequency, (b) EOD modulations, (c) locomotor activity were observed.
It has been demonstrated that the Neuro-Behavioral Assay is not only applicable to screening of water-soluble anesthetic compounds but also to compounds with sedative side-effects, as found in a large number of over-the-counter drugs. Proof-of-concept was established by demonstrating a pronounced effect of the cough suppressant “RoboTablets” (the active ingredient is dextromethorphan) at a concentration of 0.002%. The following effects were found: (a) manifold increase in EOD modulations (‘chirps’); (b) enormous increase in locomotor activity, including rolling of body along the longitudinal axis. This demonstration is highly significant, as it indicates potential for tremendous broadening of the market for application of the Neuro-Behavioral Assay.
All U.S. and PCT patent application publications and U.S. patents mentioned herein are hereby incorporated by reference in their entirety as if each individual publication or patent was specifically and individually indicated to be incorporated by reference. In case of conflict, the present application, including any definitions herein, will control.
While specific embodiments of the subject invention have been discussed, the above specification is illustrative and not restrictive. Many variations of the invention will become apparent to those skilled in the art upon review of this specification and the claims below. The full scope of the invention should be determined by reference to the claims, along with their full scope of equivalents, and the specification, along with such variations.
This application claims the benefit of priority to U.S. Provisional Patent Application No. 63/432,150, filed Dec. 13, 2022.
This invention was made with government support under Grant Number 1946910 awarded by the National Science Foundation. The government has certain rights in the invention.
Number | Date | Country | |
---|---|---|---|
63432150 | Dec 2022 | US |